Literature DB >> 15729525

Angiotensin I converting enzyme polymorphism effects in patients with normal pressure hydrocephalus syndrome before and after surgery.

Maria del Mar Matarín1, Maria Antonia Poca, David Bartrés-Faz, Maria Mataró, Imma C Clemente, Cristina Solé-Padullés, Emili González-Pérez, Pedro Moral, Maite Barrios, Carme Junqué, Juan Sahuquillo.   

Abstract

Previous reports have suggested an association between the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE), cardiovascular disease, and cognitive performance. Normal pressure hydrocephalus (NPH) is considered to be an example of reversible dementia although the clinical improvement after shunting varies from subject to subject. An association has been suggested between vascular risk factors and the development of NPH. The ACE plays a major role in vascular pathology and physiology. In the present study we investigated the distribution of an ACE gene insertion/deletion polymorphism in 112 patients diagnosed with NPH and in 124 controls. We also evaluated the role of this genetic polymorphism in cognitive functioning before and following surgery in a subgroup of 72 patients. No differences in genetic or allele distributions were found between patients and healthy subjects, but among patients, carriers of D/D or D/I genotypes obtained less cognitive benefit following shunt surgery, especially on measures of memory and frontal function. Our data support previous findings in other conditions indicating that possession of at least one D allele is associated with poorer cognitive performance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15729525     DOI: 10.1007/s00415-005-0630-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME.

Authors:  R D ADAMS; C M FISHER; S HAKIM; R G OJEMANN; W H SWEET
Journal:  N Engl J Med       Date:  1965-07-15       Impact factor: 91.245

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

4.  APO E polymorphism in Spanish and Moroccan populations.

Authors:  N Valveny; E Esteban; M Kandil; P Moral
Journal:  Clin Genet       Date:  1997-05       Impact factor: 4.438

5.  The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics.

Authors:  S Hakim; R D Adams
Journal:  J Neurol Sci       Date:  1965 Jul-Aug       Impact factor: 3.181

6.  White matter lesions in patients with idiopathic normal pressure hydrocephalus and in an age-matched control group: a comparative study.

Authors:  J K Krauss; J P Regel; W Vach; M Orszagh; F D Jüngling; M Bohus; D W Droste
Journal:  Neurosurgery       Date:  1997-03       Impact factor: 4.654

7.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

8.  The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment.

Authors:  P Amouyel; F Richard; D Cottel; C Amant; V Codron; N Helbecque
Journal:  Neurosci Lett       Date:  1996-10-18       Impact factor: 3.046

9.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

10.  Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.

Authors:  P G Kehoe; C Russ; S McIlory; H Williams; P Holmans; C Holmes; D Liolitsa; D Vahidassr; J Powell; B McGleenon; M Liddell; R Plomin; K Dynan; N Williams; J Neal; N J Cairns; G Wilcock; P Passmore; S Lovestone; J Williams; M J Owen
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.